Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Lung and liver macrophages protect our tissues and their dysfunction can cause various diseases.

A woman and her guinea pig were successfully treated for a fungal infection.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

15-Gy x-ray irradiation temporarily alters rat calvaria skin without causing significant inflammation or fibrosis.

A man with a skin nodule was diagnosed with a rare skin condition called cutaneous focal mucinosis, which can be confused with other skin cancers.

Unusual fungal structures were found in a boy's scalp infection, successfully treated with medication.

The study found certain scalp biopsy features can help tell apart alopecia areata from pattern hair loss even when typical immune cells are not seen.

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

Modulating the BTNL2 pathway can prevent hair loss in mice.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Biomaterial characteristics can influence macrophages to promote healing and improve tissue regeneration.

Some immunosuppressed patients can get unusual skin infections from Malassezia, which can be treated with antifungal medication.

Basal cell carcinomas need extra mutations to grow from small to large tumors.

Pancreatic cancer can alter gut and skin bacteria, possibly causing skin issues.

A rare skin condition in a boy is likely due to a specific genetic mutation pattern.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Mitochondrial stress can lead to atopic dermatitis.

AMT may cause hair loss and changing dWAT activity could help treat it.

Methylene blue staining effectively reveals detailed nerve structures in rat snouts.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.